This Hims & Hers Move Could Disrupt Competing Firms
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
Index funds offer broad diversification with low fees, making them a solid foundation for retirement portfolios. This guide outlines how to choose and allocate them.
25,366 articlesHims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
Delek US shares jumped as crude and refining margins strengthened. This article breaks down the drivers, the risks, a...
Wine stocks rallied on optimism around premium wine demand and stronger consumer spending. Analysts say premiumizatio...
The MLS/CLAW announces a sweeping tweak to its IDX policy and will add Compass’s full active listings, aiming to boos...
Ferrari delivered a quarter that topped estimates, yet the stock moved lower. This piece deciphers what drove the bea...
As defense demand accelerates, Anduril Industries partnering with Rocket Lab to tackle hypersonics could reshape fund...
Dell Technologies rides a booming AI infrastructure cycle into 2027, with a record AI backlog and ambitious revenue t...
Memory-chip demand has surged with AI and cloud growth, but timing still matters. This guide breaks down how to evalu...
As consumer debt climbs, a sharp cost comparison shows bankruptcy can wipe out unsecured balances in months, while lo...
Goldman Sachs marks Nvidia and Micron as the leading AI winners ahead of the upcoming earnings season, triggering fre...
Investors cheered a decisive move higher as Okta unveiled AI-powered growth opportunities. The stock touched a new 52...
Anthropic is widening who can tap into Claude Mythos, just as IPO chatter heats up in the AI arena. This move could r...